ERIBULIN MESYLATE - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2025-12-10
- Label type
- Indexing - Product Concept
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-05 00:26:36
Label at a glance#
ProductERIBULIN MESYLATE
Active ingredientERIBULIN MESYLATE
Products#
Every source-derived product name is available through these pages.
- ERIBULIN MESYLATE
- ERIBULIN
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ERIBULIN MESYLATE | AV9U0660CW | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eribulin mesylate | ERIBULIN MESYLATE | Apotex Corp. | 7752b084-cdc7-6eac-e294-e45db82c372a | 2026-08-31 | Warnings, Adverse reactions | eribulin mesylate ERIBULIN MESYLATE |
| eribulin mesylate | ERIBULIN MESYLATE | Gland Pharma Limited | f57835e2-4c53-4e93-b54b-7d7a5000ae3d | 2026-07-21 | Warnings, Adverse reactions | eribulin mesylate ERIBULIN MESYLATE |
| Eribulin Mesylate | ERIBULIN MESYLATE | BluePoint Laboratories | 1a1a9cff-d5da-4232-b98f-26f55208dfc4 | 2026-03-25 | Warnings, Adverse reactions | Eribulin Mesylate ERIBULIN MESYLATE |
| ERIBULIN MESYLATE | ERIBULIN MESYLATE | XGen Pharmaceuticals DJB, Inc. | 4d3a9ac3-10e9-cad5-e063-6394a90a461f | 2026-03-16 | Warnings, Adverse reactions | ERIBULIN MESYLATE ERIBULIN MESYLATE |
| Halaven | ERIBULIN MESYLATE | BSP Pharmaceuticals SpA | 8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6 | 2026-01-26 | ERIBULIN MESYLATE | |
| Eribulin Mesylate | ERIBULIN MESYLATE | Dr. Reddys Laboratories Inc | 1038e984-3bf7-5bbf-f1ec-ce15ae330efc | 2026-01-20 | Warnings, Adverse reactions | Eribulin Mesylate ERIBULIN MESYLATE |
| Eribulin Mesylate | ERIBULIN MESYLATE | Northstar Rx LLC | 5caedc93-c3c4-45e5-a2c6-0ce069860584 | 2025-12-01 | Warnings, Adverse reactions | Eribulin Mesylate ERIBULIN MESYLATE |
| ERIBULIN MESYLATE | ERIBULIN MESYLATE | HIKMA PHARMACEUTICALS USA INC. | aa69e7a5-fa82-4984-b9d2-653c772b80e3 | 2025-11-25 | Warnings, Adverse reactions | ERIBULIN MESYLATE ERIBULIN MESYLATE |
| Halaven | ERIBULIN MESYLATE | Eisai Inc. | 31ce4750-ded5-4a0b-95e9-f229fa6bc822 | 2025-11-07 | Warnings, Adverse reactions | ERIBULIN MESYLATE |
| ERIBULIN MESYLATE | ERIBULIN MESYLATE | GLENMARK PHARMACEUTICALS INC., USA | 55f4017d-5ea8-4622-bf59-9b9c329097fd | 2025-10-03 | Warnings, Adverse reactions | ERIBULIN MESYLATE ERIBULIN MESYLATE |
| ERIBULIN MESYLATE | ERIBULIN MESYLATE | Kindos Pharmaceuticals Co., Ltd. | 9bfd8ac7-57e2-4c9d-add8-26502cfb54a8 | 2025-08-07 | Warnings, Adverse reactions | ERIBULIN MESYLATE ERIBULIN MESYLATE |
| ERIBULIN MESYLATE | ERIBULIN MESYLATE | Sun Pharmaceutical Industries Limited | 2c0e145b-96b0-4f7b-8993-0f5f59afa81d | 2025-05-06 | Warnings, Adverse reactions | ERIBULIN MESYLATE ERIBULIN MESYLATE |
| Eribulin Mesylate | ERIBULIN MESYLATE | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 8a81f3e9-ac52-4f98-bf62-da7974d012b3 | 2025-03-07 | Warnings, Adverse reactions | Eribulin Mesylate ERIBULIN MESYLATE |
| Eribulin Mesylate | ERIBULIN MESYLATE | Sandoz Inc | d122f0a4-aff7-49f7-8cf1-06bc2883ad43 | 2024-10-02 | Warnings, Adverse reactions | Eribulin Mesylate ERIBULIN MESYLATE |
| Eribulin Mesylate | ERIBULIN MESYLATE | Baxter Healthcare Company | 62690292-b1de-46f1-b6e8-012a725f8c63 | 2024-10-01 | Warnings, Adverse reactions | Eribulin Mesylate ERIBULIN MESYLATE |
| Eribulin Mesylate | ERIBULIN MESYLATE | Long Grove Pharmaceuticals, LLC | 4a64918a-f674-4843-b544-ab815fdd1b8f | 2024-05-31 | Warnings, Adverse reactions | Eribulin Mesylate ERIBULIN MESYLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.